{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP00252",
    "Peptide Name": "MCF (melittin C-terminal fragment, UCLL1; Synthetic AMPs20)",
    "Source": "Sequence truncation",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GLPALISWIKRKRQQ",
    "Sequence Length": 25,
    "UniProt Entry": "P56236",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 1,
    "Boman Index": 2.04,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "48%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "57.69% similar to its parent peptide Melittin (AP00146).Activity: Active against E. coli W 160-37 (MIC 35-45 ug/ml), S. aureus 8530B (MIC 25-35 ug/ml), B. subtilis (MIC 15-25 ug/ml), and P.putida NCIM 2102 (MIC >200 ug/ml).Toxicity: HC50 reached 100 ug/ml comapred to the parent peptide (HC50 < 1 ug/ml).SAR: The peptide has reduced antibacterial activity and 300 fold less hemolytic.Caerin 2.5 has been merged with Caerin 2.2 since they share the same sequence. Updated 7/2021.",
    "Author": "Subbalakshmi C, Nagaraj R, Sitaram N. 1999",
    "Reference": "FEBS Lett. 1999 Apr 1;448(1):62-6. doi: 10.1016/s0014-5793(99)00328-2.PubMed.",
    "Title": "Biological activities of C-terminal 15-residue synthetic fragment of melittin: design of an analog with improved antibacterial activity"
  },
  "3D Structure": []
}